Research Paper Volume 16, Issue 1 pp 872—910
XRCC1: a potential prognostic and immunological biomarker in LGG based on systematic pan-cancer analysis
Figure 4. XRCC1 expression levels could distinguish between cancerous and normal tissues in pan-cancer. (A) ACC; (B) BLCA; (C) BRCA; (D) CESC; (E) CHOL; (F) COAD; (G) DLBC; (H) ESCA; (I) GBM; (J) HNSC; (K) KIRC; (L) KIRP; (M) LGG; (N) LIHC; (O) OSCC; (P) PAAD; (Q) READ; (R) SKCM; (S) STAD; (T) THYM. X-axis reveals the false positive rate, while Y-axis indicates the true positive rate.